For a second year, Genetic Signatures Ltd are proudly exhibiting at the 25th International Molecular Medicine TRI-Conference (MMTC) in San Francisco, CA on 12th-14thFebruary 2018.
Our US operations team will be exhibiting our growing number of EasyScreenTM viral and infectious disease reagents. Formulated on our proprietary 3base™ technology, the EasyScreenTM reagents fosters more efficient detection of infectious microorganisms, within a streamlined workflow solution. The EasyScreenTM reagents includes targets for diagnosing bacterial, viral and protozoan causes of gastroenteritis; respiratory infections, sexually transmitted infections, and antibiotic resistance.
Visit Genetic Signatures at Booth 221 MMTC 2018 for more information
Don’t forget to follow us on Twitter @GeneticSig for updates throughout the conference.
About MMTC 2018: MMTC also known as Tri-Con, is an annual precision medicine event attracting over 3,700 drug discovery and development professionals worldwide. Spanning five days, the 2018 meeting includes over 500 fellow industry and academic colleagues discussing themes of cancer research, big data, molecular diagnostics, precision medicine, rare diseases, data science, human microbiome, point-of-care diagnostics, infectious diseases, and so much more.